FrancophonIA/ELRC3.0 huggingface dataset:
English: The exposure of lansoprazole is several-fold higher in PMs than in extensive metabolisers (EMs).
Slovenian: Pri PM je izpostavljenost lansoprazolu nekajkrat večja kot pri dobrih presnavljalcih (Em - Extensive Metaboliser).
English: Adverse drug reactions such as dizziness and fatigue may occur (see section 4.8 undesirable effects).
Slovenian: 4.7 Vpliv na sposobnost vožnje in upravljanja s stroji Lahko se pojavijo neželene reakcije na zdravilo, kot sta vrtoglavica in utrujenost (glejte poglavje 4.8
English: Increase bioaivalability and half-life of lansoprazole by 30 % each; increased plasma amoxicillin levels of a clarithromycin metabolite by 30 %
Slovenian: Povečana biološka razpoložljivost in razpolovni čas lansoprazola za 30 %; povečana plazemska koncentracija presnovka klaritromicina za 30 %
English: [To be completed nationally]
Slovenian: [Podatke je treba dopolniti v posameznih državah]
English: Therapy of Helicobacter pyloti infection is intended to be combined with concurrent administration of lansoprazole, clarithromycin and a further antibiotic.
Slovenian: Zdravljenje okužbe z bakterijo Helicobacter pylori poteka kot kombinirano zdravljenje z lansoprazolom, klaritromicinom in dodatnim antibiotikom.
English: Antacids and sucralfate may reduce the bioavailability of lansoprazole.
Slovenian: Antacidi in sukralfat lahko zmanjšajo biološko razpoložljivost lansoprazola.
English: The possibility of malignant gastric tumour should be excluded before initiating treatment of gastric ulcer with lansoprazole, because lansoprazole can mask the symptoms and delay the diagnosis.
Slovenian: Pred začetkom zdravljenja razjede želodca z lansoprazolom je treba izključiti možnost malignega tumorja želodca, ker lahko lansoprazol zamaskira simptome in prepreči pravočasno diagnosticiranje.
English: +/K +ATPase causing inhibition of the enzyme activity.
Slovenian: +ATPaze, kar povzroči zaviranje encimske aktivnosti.
English: Benefit/Risk considerations Available data support the use of lansoprazole-amoxicillin-clarithromycin as a first-line treatment.
Slovenian: Razpoložljivi podatki podpirajo uporabo kombinacije lansoprazol-amoksicilin-klaritromicin kot prvenstvenega zdravljenja.
English: In mice dose-related gastric ECL cell hyperplasia developed as well as liver tumours and adenoma of rete testis.
Slovenian: Pri miših so se razvili hiperplazija želodčnih celic ECL, tumorji na jetrih in adenom mrežja testisa.
English: In case of clarithromycin resistance, or treatment failure, the combination of lansoprazole-amoxicillinmetronidazole may be used, and in case of beta-lactam allergy the combination of lansoprazoleclarithromycin-metronidazole is advisable.
Slovenian: V primeru odpornosti proti klaritromicinu ali kadar je zdravljenje neuspešno, je priporočljiva uporaba kombinacije lansoprazol-amoksicilin-metronidazol.
English: Opaque, yellow hard gelatine capsule, containing pellets with enteric coating.
Slovenian: Neprozorne, rumene, trde želatinaste kapsule, ki vsebujejo pelete z enterično oblogo.
English: MARKETING AUTHORISATION NUMBER [To be completed nationally]
Slovenian: ŠTEVILKA DOVOLJENJA ZA PROMET [Podatke je treba dopolniti v posameznih državah]
English: Opaque, white hard gelatine capsule, containing pellets with enteric coating.
Slovenian: Neprozorne, bele, trde želatinaste kapsule, ki vsebujejo pelete z enterično oblogo.
English: Lansoprazole is rapidly inactivated by gastric acid and lansoprazole is consequently administered as enteric coated granules in gelatin capsules.
Slovenian: Želodčna kislina hitro inaktivira lansoprazol, ki se zato daje v obliki granul z enterično oblogo v želatinastih kapsulah.
English: The concerns rose referred to discrepancies in comparison to the reference products on posology.
Slovenian: Zadržki so bili predloženi zaradi neskladnosti pri primerjavah z referenčnimi zdravili v zvezi z odmerjanjem.
English: Lansoprazole has been observed to inhibit the transport protein, P-glycoprotein (Pgp) in vitro.
Slovenian: Opazili so, da lansoprazol in vitro zavira transportno beljakovino P-glikoprotein (Pgp).
English: clarithromycin (C) and amoxycillin (A) (PCA) vs. those using proton pump inhibitor, clarithromycin and a nitroimidazole (N) (PCN) for H. pylori eradication provided evidence in support of similar H. pylori eradication efficacy.
Slovenian: V meta-analizi raziskav, ki so primerjale enotedensko trotirno zdravljenje s kombinacijo zaviralca protonske črpalke, klaritromicina (C) in amoksicilina (A) (PCA) ter kombinacijo zaviralca protonske črpalke, klaritromicina in nitroimidazola (N) (PCN) za eradikacijo H. pylori z odmerki dvakrat dnevno, so ugotovili podobno učinkovitost eradikacije H. pylori.
English: Intestinal metaplasia has been found in animal studies on rats.
Slovenian: V študijah na podganah so odkrili intestinalno metaplazijo.
English: Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, toxicity to reproduction or genotoxicity.
Slovenian: 5.3 Predklinični podatki o varnosti Predklinični podatki na podlagi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih se odmerkih in genotoksičnosti ne kažejo posebnega tveganja za ljudi.
English: Caution is adviced during cotreatment with carbamazepin (a CYP3A substrate) and lansoprazole.
Slovenian: Med sočasnim zdravljenjem s karbamazepinom (substratom encima CYP3A) in lansoprazolom se priporoča previdnost.
English: Eradication of H. pyolori and peptic ulcer healing
Slovenian: Eradikacija H. pylori in zdravljenje želodčne razjede
English: Skin and hair eczema, urticaria and itching.
Slovenian: Koža in lasje ekcem, urtikarija in srbenje.
English: In patients with moderately impaired hepatic function, the dose should be restricted to 15 mg daily.
Slovenian: Pri bolnikih z zmerno okvaro delovanja jeter, odmerek ne sme preseči 15 mg dnevno.
English: Coadministration of lansoprazole increases the plasma concentrations of tacrolimus (a CYP3A and P-gp substrate).
Slovenian: Sočasna uporaba z lansoprazolom poveča koncentracijo takrolimusa (substrat encimov CYP3A in P-gp) v plazmi.
English: 30 mg inhibits pentagastrin-stimulated gastric acid secretion by about 80%.
Slovenian: En 30-miligramski peroralni odmerek lansoprazola zavre izločanje želodčne kisline, ki ga spodbuja pentagastrin, za približno 80 %.
English: (See Section 4.2 “
Slovenian: (Glejte poglavje 4.2 Odmerjanje in način uporabe)
English: Administration of lansoprazole may result in subtherapeutic concentrations of ketoconazol and itraconazol and the combination should be avoided.
Slovenian: Uporaba lansoprazola lahko zmanjša koncentracijo ketokonazola in itrakonazola pod terapevtsko raven, zato se je treba kombinaciji teh zdravil izogibati.
English: In patients not fully healed within this time, the medication should be continued at the same dose for another two weeks.
Slovenian: Pri bolnikih, ki se ne pozdravijo v tem času, je treba zdravljenje z istim odmerkom nadaljevati še dva tedna.
English: Fluvoxamine, an inhibitor of CYP2C19, increased the plasma concentrations of lansoprazole up to 4-fold.
Slovenian: CYP2C19, fluvoksamin, je povečal koncentracijo lansoprazola v plazmi do 4-krat.
English: The Summary of Products Characteristic proposed by the applicant has been assessed based on the documentation submitted and the scientific discussion within the Committee.
Slovenian: Ker je bil namen napotitve uskladiti Povzetek glavnih značilnosti zdravila glede odmerjanja pri eradikacijskem zdravljenju H. pylori je bil Povzetek glavnih značilnosti zdravila, ki ga je predlagal vlagatelj, ovrednoten na podlagi predložene dokumentacije in znanstvene razprave znotraj Odbora,
English: leucopenia.
Slovenian: levkopenija.
English: Caution is advised when combining lansoprazole with drugs which are metabolised by this enzyme.
Slovenian: Pri kombiniranju lansoprazola z zdravili, ki jih presnavlja ta encim, se priporoča previdnost.
English: The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication should be continued at the same dose for another 4 weeks.
Slovenian: Razjeda se ponavadi zaceli v 4 tednih, vendar je treba pri bolnikih, ki se ne pozdravijo v tem času, zdravljenje podaljšati z istim odmerkom za
English: • Long-term prophylaxis of reflux oesophagitis.
Slovenian: • Dolgotrajna profilaksa refluksnega ezofagitisa.
English: For lansoprazole no clinical data on exposed pregnancies are available.
Slovenian: 4.6 Nosečnost in dojenje Za lansoprazol ni kliničnih podatkov o uporabi med nosečnostjo.
English: • Treatment of reflux oesophagitis.
Slovenian: • Zdravljenje refluksnega ezofagitisa.
English: Cardiovascular peripheral edema,
Slovenian: Srce in ožilje periferni edem,
English: Nature and Contents of Container
Slovenian: 6.5 Vrsta ovojnine in vsebina
English: Drugs which inhibits CYP3A4
Slovenian: Zdravila, ki zavirajo CYP3A4
English: 30 mg + 500 mg 3 times/day for 5 days
Slovenian: 30 mg + 500 mg 3-krat/dan, 5 dni
English: Gastrointestinal nausea, diarrhoea, stomach ache, constipation, vomiting, flatulence and dyspepsia.
Slovenian: Bolezni prebavil navzeja, driska, bolečine v trebuhu, zaprtje, bruhanje, vetrovi in dispepsija.
English: The enzyme CYUP3A4
Slovenian: CYUP3A4.
English: Absorption from the duodenum is rapid and plasma peak concentration is achieved within 1.5-2.0 hours.
Slovenian: Absorpcija iz dvanajstnika je hitra in največja koncentracija v plazmi se doseže v
English: There is no need to change the dose in patients with impaired renal function.
Slovenian: Pri bolnikih z okvarjenim delovanjem ledvic odmerka ni treba prilagajati.
English: 3 years
Slovenian: 6.3 Rok uporabnosti 3 leta
English: Instructions for Use and Handling No special requirements.
Slovenian: Ni posebnih zahtev.
English: Drugs metabolised by CYP3A4
Slovenian: Zdravila, ki jih presnavlja CYP3A4
English: Triple therapy allows the eradication of H. pylori in more than 85% of cases in patients with peptic ulcer.
Slovenian: pylori pri več kot 85 % bolnikov z želodčno razjedo.
English: itraconazole, protease inhibitors, macrolides etc may markedly increase the plasma concentrations of lansoprazole.
Slovenian: Zdravila, ki zavirajo CYP3A4, kot so ketokonazol, itrakonazol, zaviralci proteaz, makrolidi itn., lahko bistveno povečajo koncentracijo lansoprazola v plazmi.
English: Lansoprazole 15 mg:
Slovenian: Lansoprazol 15 mg:
English: Lansoprazole 30 mg:
Slovenian: Lansoprazol 30 mg:
English: Patients suffering from gastro-duodenal ulcers, the possibility of H. pylori infection as an etiological factor should be considered.
Slovenian: Pri bolnikih z razjedami želodca in dvanajstnika je treba upoštevati možnost okužbe z bakterijo H.
English: Summary of Product Characteristics as set out in Annex III for Lansopon and associated names (see
Slovenian: je Odbor za zdravila za uporabo v humani medicini priporočil odobritev dovoljenj za promet z zdravilom s spremembami Povzetka glavnih značilnosti zdravila, kakor je opredeljeno v Dodatku III za Lansopon in povezana imena (glejte Dodatek I).
English: Three metabolites have been identified in the urine: 5-hydroxy sulphone, 5
Slovenian: V urinu so odkrili tri presnovke: 5-hidroksi sulfon, 5-hidroksi sulfid in 5-hidroksi lansoprazol.
English: hepatitis, icterus and interstitial nephritis.
Slovenian: Povečanje ravni jetrnih encimov hepatitis, ikterus in intersticijski nefritis.
English: The normal daily dose of 30 mg should not be exceeded in these patients, however.
Slovenian: Vendar pri teh bolnikih odmerek ne sme preseči 30 mg dnevno.
English: Studies have shown that the dosage of phenytoin (CYP2C19 and CYP2C9 substrate) may have to be reduced when administered concomitantly with lansoprazole.
Slovenian: Študije so pokazale, da je morda treba zmanjšati odmerjanje fenitoina (substrata encimov CYP2C19 in
English: Lansoprazole should be used with caution in patients with severe hepatic dysfunction.
Slovenian: Pri bolnikih s hudo okvaro delovanja jeter je treba lansoprazol uporabljati zelo previdno.
English: Treatment of reflux oesophagitis:
Slovenian: Zdravljenje refluksnega ezofagitisa:
English: In two rat carcinogenicity studies, lansoprazole produced dose-related gastric ECL cell hyperplasia and
Slovenian: V dveh študijah karcinogenosti na podganah je lansoprazol povzročil od odmerka odvisno hiperplazijo želodčnih celic ECL in karcinoide celic ECL, povezane s hipergastrinemijo zaradi zaviranja izločanja kisline in atrofijo mrežnice.
English: Musculoskeletal and connective tissue disorders muscle and joint pain
Slovenian: Bolezni mišično skeletnega sistema in bolečine v mišicah in sklepih vezivnega tkiva Čutila motnje okusa in vida.
English: Warfarin
Slovenian: Teofilin
English: The lansoprazole dose should therefore be taken at least an hour prior or after.
Slovenian: Antacidi in sukralfat lahko zmanjšajo biološko uporabnost lansoprazola, zato je treba odmerek lansoprazola vzeti vsaj eno uro prej ali pozneje.
English: Effect on gastric acid secretion: Lansoprazole is a specific inhibitor of the parietal cell proton pump.
Slovenian: Lansoprazol je specifični zaviralec protonske črpalke parietalnih celic.
English: H. pylori eradication rate of between 80 and 90%.
Slovenian: Za kombinacijo lansoprazola z antibiotiki v dvotirnem ali trotirnem zdravljenju je bila dokazana stopnja eradikacije H. pylori v razponu med 80 in 90 %.
English: Special Precautions for Storage Do not store above 25ºC.
Slovenian: Zdravilo shranjujte pri temperaturi do 25 °C.
English: Mannitol Hypromellose Macrogol 6000 Talc
Slovenian: Makrogol 6000
English: [To be completed nationally] 4.
Slovenian: [Podatke je treba dopolniti v posameznih državah] 6.2 Inkompatibilnosti
English: also contributes to the metabolism.
Slovenian: K presnovi prispeva tudi encim
English: Titanium dioxide (E 171) In addition for Lansoprazole 15 mg: Quinoline yellow (E 104) [To be completed nationally] 6.2.
Slovenian: Pri zdravilu Lansoprazol 15 mg tudi: Kinolinsko rumeno (E 104)
English: MARKETING AUTHORISATION HOLDER [To be completed nationally]
Slovenian: IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM [Podatke je treba dopolniti v posameznih državah]
English: Pharmacokinetic Properties
Slovenian: 5.2 Farmakokinetične lastnosti
English: Posology and Method of Administration
Slovenian: 4.2 Odmerjanje in način uporabe
English: methacrylic acid ethyl acrylate copolymer, 1:1, dispersion 30 % Capsule shell:
Slovenian: Titanov dioksid (E 171) kopolimer metilakrilne kisline in etilakrilata (1:1, 30-odstotna disperzija)
English: ATPase of the parietal cells in the stomach.
Slovenian: ATPaze parietalnih celic želodca zavira končno stopnjo tvorbe želodčne kisline.
English: Due to the lack of data in patients with severely impaired hepatic function, these patients should not be treated with lansoprazole (see section 4.4 “Special warnings and precautions for use”).
Slovenian: Zaradi pomanjkanja podatkov, bolnikov s hudo okvaro delovanja jeter ne smemo zdraviti z lansoprazolom
English: amoxicillin
Slovenian: amoksicilin
English: Lansoprazole 30 mg combined with amoxicillin 1g, clarithromycin 250 or 500 mg, or metronidazole 400
Slovenian: klaritromicinom 250 ali 500 mg ali metronidazolom 400 mg dvakrat dnevno dokazali 71- do 94
English: Caution and increased monitoring frequency is advised when initiating or ending lansoprazole co treatment in patients treated with warfarin.
Slovenian: Varfarin Ob začetku in koncu sočasnega zdravljenja z lansoprazolom in varfarinom se priporočata previdnost in pogostejši nadzor.
English: mg of lansoprazole have been administered in trials without significant undesirable effects.
Slovenian: V preskušanjih so brez bistvenih neželenih učinkov uporabili odmerke do 180 mg lansoprazola dnevno.
English: Treatment of duodenal ulcer: The recommended dose is 30 mg once daily for 2 weeks.
Slovenian: Zollinger-Ellisonov sindrom: Priporočeni začetni odmerek je 60 mg enkrat dnevno.
English: mg twice daily was associated with eradication rates ranging from 71 to 94%, and ulcer healing rates were generally >80% in well designed studies.
Slovenian: odstotno stopnjo eradikacije ter običajno >80-odstotno stopnjo zaceljenja razjede.
English: It inhibits the final stage of gastric acid formation by inhibiting the activity of H +/K
Slovenian: Z zaviranjem aktivnosti H
English: glossitis, candidiasis of oesophagus, pancreatitis colitis, stomatitis and black tongue.
Slovenian: glositis, kandidiaza ezofagusa, pankreatitis kolitis,
English: Undesirable effects for possible symptoms of lansoprazole overdose.
Slovenian: Možni simptomi prevelikega odmerjanja lansoprazola so v poglavju 4.8 Neželeni učinki.
English: Holder
Slovenian: Zaviralec
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, and marketing authorisation holders in the Member States
Slovenian: Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe zdravila, imetnikov dovoljenja za promet z zdravilom v državah članicah
English: Denmark Eli Lilly Danmark A/S Lyskær 3E, 2.tv.
Slovenian: Eli Lilly Danmark A/S Lyskær 3E, 2.tv.
English: Nebido parenteral use
Slovenian: Nebido parenteralna uporaba
English: Sweden Eli Lilly Sweden AB Box 721
Slovenian: Eli Lilly Sweden AB Box 721
English: 203 11 Malmö
Slovenian: 203 11 Malmö Sweden
English: 169 27 Solna
Slovenian: 169 27 Solna Sweden
English: Ringener Str. 45
Slovenian: KG Ringener Str. 45
English: Eli Lilly Norge AS P.B.
Slovenian: Norveška Eli Lilly Norge AS P.B.
English: Ferring Magyarország Gyógyszerkereskedelmi Kft. Tomori u. 34.
Slovenian: Madžarska Ferring Magyarország Gyógyszerkereskedelmi Kft. Tomori u. 34.
English: Sweden Ferring Läkemedel AB Box 4041
Slovenian: Ferring Läkemedel AB Box 4041
English: 79111 Freiburg
Slovenian: 79111 Freiburg Germany
English: DK-2730 Herlev
Slovenian: DK-2730 Herlev Denmark
English: Germany MSD Sharp&Dohme Gesellschaft mit beschränkter Haftung Lindenplatz 1
Slovenian: MSD Sharp&Dohme Gesellschaft mit beschränkter Haftung Lindenplatz 1
English: Agovirin depot suspension for injection
Slovenian: Agovirin depot suspenzija za injiciranje
English: Ferring PortuguesaProdutos Farmacêuticos, Sociedade Unipessoal, Lda.
Slovenian: Portugalska Ferring PortuguesaProdutos Farmacêuticos, Sociedade Unipessoal, Lda.
English: Pierre Fabre Médicament Portugal, Lda.
Slovenian: Portugalska Pierre Fabre Médicament Portugal, Lda.
English: Luxembourg Eli Lilly Benelux S.A. -N.V 1, rue du Marquis
Slovenian: Luksemburg Eli Lilly Benelux S.A. -N.V 1, rue du Marquis
English: N.V. Organon Postbus 20
Slovenian: Organon Postbus 20
English: 33611 Bielefeld
Slovenian: 33611 Bielefeld Germany
English: capsules oral use
Slovenian: kapsula peroralna uporaba
English: Germany Lilly Deutschland GmbH Teichweg 3
Slovenian: Lilly Deutschland GmbH Teichweg 3
English: 1000 Brussels
Slovenian: 1000 Brussels Belgium
English: Belgium Bayer SA-NV Jan Emiel Mommaertslaan
Slovenian: Bayer SA-NV Jan Emiel Mommaertslaan
English: Polarisavenue 130 2132 JX Hoofddorp The Netherlands testosteron
Slovenian: 2132 JX Hoofddorp The Netherlands testosteron
English: Luxembourg Ferring S.A. 93C, Capucienenlaan 9300 Aalst
Slovenian: Luksemburg Ferring S.A. 93C, Capucienenlaan 9300 Aalst
English: Germany Eifelfango ChemischPharmazeutische Wrke GmbH&Co.
Slovenian: Eifelfango ChemischPharmazeutische Wrke GmbH&Co.
English: Germany Ferring Arzneimittel GmbH Fabrikstr.7
Slovenian: Ferring Arzneimittel GmbH Fabrikstr.7
English: Germany Dr. August Wolff GmbH&Co.
Slovenian: Dr. August Wolff GmbH&Co.
English: Germany Pierre Faber Pharma GmbH Jechtlinger Str. 13
Slovenian: Pierre Faber Pharma GmbH Jechtlinger Str. 13
English: Organon (Ireland) Limited PO Box 2857, Drynam Road, Swords Co. Dublin Ireland testosterone undecanoate Restandol Testocaps 40 mg capsules, soft oral use
Slovenian: Organon (Ireland) Limited PO Box 2857, Drynam Road, Swords Co. Dublin Ireland testosterone undecanoate Restandol Testocaps 40 mg kapsula, mehka peroralna uporaba
English: capsule, soft oral use
Slovenian: kapsula, mehka peroralna uporaba
English: Hertford Road Hoddesdon Hertfordshire EN11 9BU United Kingdom testosterone undecanoate Restandol 40mg capsule oral use
Slovenian: Hertford Road Hoddesdon Hertfordshire EN11 9BU United Kingdom testosterone undecanoate Restandol 40mg kapsula peroralna uporaba
English: DE-13342 Berlin
Slovenian: D-13342 Berlin
English: Germany Jenapharm GmbH&CO.
Slovenian: Jenapharm GmbH&CO.
English: BAYER SANTE 220, avenue de la Recherche 59120 Loos France testosterone undecanoate NEBIDO 1000 mg/4 ml, solution injectable
Slovenian: BAYER SANTE 220, avenue de la Recherche 59120 Loos France testosterone undecanoate NEBIDO 1000 mg/4 ml, solution injectable raztopina
English: Belgium Ferring SA-NV Capucienenlaan 93C 9300 Aalst
Slovenian: Ferring SA-NV Capucienenlaan 93C 9300 Aalst Belgium
English: Aspen Pharma Trading Limited.3016 Lake Drive.
Slovenian: Portugalska Aspen Pharma Trading Limited.3016 Lake Drive.
English: Ferring B.V.
Slovenian: Nizozemska Ferring B.V.
English: Box 20
Slovenian: Organon PO BOX 20
English: Luxembourg Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business
Slovenian: Luksemburg Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business
English: Nebido 250 mg/ml oldatos injekció intramuscular injection
Slovenian: Nebido 250 mg/ml oldatos injekció intramuskularna injekcija
English: AGOVIRIN DEPOT 5 mg/2 ml suspension for injection
Slovenian: AGOVIRIN DEPOT 5 mg/2 ml suspenzija za injiciranje
English: 92400 Courbevoie France testosterone undecanoate PANTESTONE 40 mg, capsule molle capsule, soft oral use
Slovenian: 92400 Courbevoie France testosterone undecanoate PANTESTONE 40 mg, capsule molle kapsula, mehka peroralna uporaba
English: 22,5 mg/patch patch
Slovenian: 22,5 mg/patch obliž
English: Germany GALENpharm GmbH Wittland13
Slovenian: GALENpharm GmbH Wittland13
English: ANDROTARDYL 250 mg/1 ml, solution injectable intramusculaire solution
Slovenian: ANDROTARDYL 250 mg/1 ml, solution injectable intramusculaire raztopina
English: Axiron 30mg/1,5ml Lösung zur Anwendung auf der Haut solution
Slovenian: Axiron 30mg/1,5ml Lösung zur Anwendung auf der Haut raztopina
English: 35396 Gießen
Slovenian: 35396 Gießen Germany
English: Lithuania Ferring Lääkkeet Oy PL 23
Slovenian: Ferring Lääkkeet Oy PL 23
English: N.V. Organon PO BOX 20
Slovenian: ORGANON P.O. Box 20
English: Axiron cutaneous solution
Slovenian: Axiron dermalna raztopina
English: Ferring Legemidler AS Nydalsveien 36B 0484 Oslo
Slovenian: Norveška Ferring Legemidler AS Nydalsveien 36B
English: Andriol Testocaps 40 mg - Kapseln capsule, soft oral use
Slovenian: Andriol Testocaps 40 mg - Kapseln kapsula, mehka peroralna uporaba
English: Rua Rodrigo da Fonseca 178 - 2º Esq 1099-067 Lisboa Portugal
Slovenian: Rua Rodrigo da Fonseca 178 - 2º Esq
English: Belgium Aspen Pharma Trading Limited, 3016 Lake Drive Citywest Business Campus Dublin 24
Slovenian: Aspen Pharma Trading Limited, 3016 Lake Drive Citywest Business Campus Dublin 24
English: Andriol Testocaps, 40 mg capsules capsule, soft oral use
Slovenian: Andriol Testocaps, 40 mg capsules kapsula, mehka peroralna uporaba
English: 30 mg/patch patch
Slovenian: 30 mg/patch obliž
English: Belgium Besins Healthcare Avenue Louise 287
Slovenian: Besins Healthcare Avenue Louise 287 1050 Brussels Belgium
English: 50 mg/5 g transdermal gel
Slovenian: 50 mg/5 g transdermalni gel
English: Sweden Laboratoires Besins International
Slovenian: Madžarska Laboratoires Besins International
English: Germany Laboratoires Besins international
Slovenian: Romunija LABORATOIRES BESINS INTERNATIONAL
English: 15 mg/patch patch
Slovenian: 15 mg/patch obliž
English: Luxembourg Bayer S.A.-N.V. 14, J.E.Mommaerstlaan 1831 Diegem (Machelen) Belgium testosterone undecanoate Nebido
Slovenian: 14, J.E.Mommaerstlaan 1831 Diegem (Machelen) Belgium testosterone undecanoate Nebido
English: Denmark Ferring Lægemidler A/S, Kay Fiskers Plads 11
Slovenian: Ferring Lægemidler A/S, Kay Fiskers Plads 11 DK-2300 København S Denmark
English: Germany Rotexmedica GmbH Arzneimittelwerk
Slovenian: Rotexmedica GmbH Arzneimittelwerk Bunsenstr.4
English: 2,5 mg/25 mg/ ml suspension for injection
Slovenian: 2,5 mg/25 mg/ ml suspenzija za injiciranje
English: Ferring GmbH Wittland 11
Slovenian: Slovenija Ferring GmbH Wittland 11